P Petrini

TL;DR: The frequency of joint bleeds and orthopaedic joint scores were evaluated in 121 patients with severe haemophilia who had started prophylactic treatment with clotting factor concentrates at least once weekly before the age of 10.

TL;DR: A normal vaginal delivery is to be recommended for haemophilia carrier gravidae and it is suggested that this practice should be followed on the basis of clinical practice and prior history.

TL;DR: Data suggest that long-term prophylaxis is warranted in the majority of patients with type 3 VWD and in other subtypes with severe bleeding tendencies, and that such an approach may help in the avoidance of joint disease if started early.

TL;DR: Most boys below 6 years received concentrates via a peripheral vein but three centres preferred a central venous line for 80–100% of the boys, and all but one centre preferred recombinant concentrate.

TL;DR: New scales were developed based on suggested modifications of the existing scales and called the Haemophilia Joint Health Score (HJHS) and the International MRI Scales, which promise to improve outcome assessment in children on early preventive treatment regimens.